The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer is published open access in the Green Journal. The paper describes in detail the comprehensive centralised REQUITE database and linked biobank - a valuable resource for the radiotherapy community for validating predictive models and biomarkers.
New REQUITE Concept Form template v5 is now available (see also the process for data/ sample access) www.requite.eu/node/203
The aim of this report is to provide a final update on the outputs and dissemination activities of the REQUITE consortium.
The main achievement of REQUITE was completing an observational study, the largest of its kind, which is recognised as an exemplar of the type of multi-disciplinary, multinational work that can and should be carried out in the radiotherapy-related research field.
The annual congress of ESTRO will take place 26-30 April 2019 in Milan, Italy. ESTRO 38 will offer all professionals of oncology the chance to share knowledge, practice and advances in the field, within the ever warm and dynamic environment of the ESTRO meetings. ‘Targeting optimal care, together’ will be the theme of ESTRO 38 and through these few, however impactful words, the Scientific and organising committees would like to put a spotlight on the multiprofessional and multidisciplinary aspect of our specialty. The theme also represents our strength: we are all working towards a common goal for improved patient outcomes, and this will be expressed throughout the scientific programme... See for more information the website
Nederlands
English
Français
Deutsch
Italiano
Español